Covered recipient · General Payments record
STACEY A BLYTH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,246.59
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $320.26 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $152.80 | 9 |
| Novo Nordisk AS | $65.61 | 4 |
| ABBVIE INC. | $39.48 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.16 | 1 |
| Lilly USA, LLC | $18.65 | 1 |
| Amgen Inc. | $14.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.32 | 01/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187879 | CMS |
| Abbott Laboratories | $18.49 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187883 | CMS |
| Abbott Laboratories | $21.09 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187887 | CMS |
| Abbott Laboratories | $15.10 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187891 | CMS |
| Abbott Laboratories | $18.45 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187895 | CMS |
| Abbott Laboratories | $3.29 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187911 | CMS |
| Abbott Laboratories | $15.90 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187899 | CMS |
| Abbott Laboratories | $17.02 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187903 | CMS |
| Abbott Laboratories | $24.14 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125187908 | CMS |
| ABBVIE INC. | $19.37 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103340044 | CMS |
| ABBVIE INC. | $20.11 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103340046 | CMS |
| Amgen Inc. | $14.56 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117509648 | CMS |
| Lilly USA, LLC | $18.65 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430329 | CMS |
| Novo Nordisk Inc | $14.22 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097506160 | CMS |
| Novo Nordisk Inc | $17.07 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096915108 | CMS |
| Novo Nordisk Inc | $17.65 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096817687 | CMS |
| Novo Nordisk Inc | $16.67 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096633360 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.16 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118863865 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.